Literature DB >> 2126348

[Ischemic cerebrovascular complication in tuberculous meningitis; a case of Fröhlich syndrome and hemiparesis].

S Kashiwagi1, S Abiko, K Harada, K Yamashita, H Ito.   

Abstract

A 34-year-old man came to our hospital with an episode of focal convulsion of the left arm. He had suffered from tuberculous meningitis in childhood and developed left hemiparesis and Fröhlich syndrome as sequelae. CT scan showed a calcified mass in the suprasellar cistern and a low density area suggestive of cerebral infarction in the right anterior cerebral artery distribution. The left carotid angiograms showed severe stenosis of the left internal carotid artery in the supra-clinoid segment and occlusion of the proximal middle and anterior cerebral arteries with development of moyamoya vessels as collateral circulation. The right carotid angiograms showed similar findings with less collateral circulation. At surgery, the anterior part of the Willis ring was found embedded in the suprasellar calcified granuloma. Recognition of cerebrovascular complication in tuberculous meningitis is important and an early modification of the therapy may improve the outcome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126348

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  3 in total

Review 1.  Postpneumococcal Moyamoya syndrome case report and review of the postinfective cases.

Authors:  Federica Pinardi; Andrea Stracciari; Luca Spinardi; Maria Guarino
Journal:  BMJ Case Rep       Date:  2013-02-06

Review 2.  Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.

Authors:  Takeshi Mikami; Hime Suzuki; Katsuya Komatsu; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-07-06       Impact factor: 1.742

Review 3.  Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease.

Authors:  Brandon M Fox; Kirsten B Dorschel; Michael T Lawton; John E Wanebo
Journal:  Front Neurol       Date:  2021-09-03       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.